Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Daniel Harari

Showing results (1-10 of 28) with videos related to

Pageof 3
Sort By:
Cognition|November 13, 2018
A model for discovering 'containment' relationsShimon Ullman, Nimrod Dorfman, Daniel Harari
Proceedings of the National Academy of Sciences of the United States of America|September 27, 2012
From simple innate biases to complex visual conceptsShimon Ullman, Daniel Harari, Nimrod Dorfman
Molecular and Cellular Biology|June 22, 2011
Stochastic receptor expression determines cell fate upon interferon treatmentDoron Levin, Daniel Harari, Gideon Schreiber
Proceedings of the National Academy of Sciences of the United States of America|February 18, 2016
Atoms of recognition in human and computer visionShimon Ullman, Liav Assif, Ethan Fetaya, et al.
Molecular and Cellular Biology|July 1, 2009
Receptor density is key to the alpha2/beta interferon differential activitiesIgnacio Moraga, Daniel Harari, Gideon Schreiber, et al.
The British Journal of General Practice : the Journal of the Royal College of General Practitioners|April 5, 2008
Sexual problems in later lifeSteve Iliffe, Kalpa Kharicha, Daniel Harari, et al.
Plos One|July 10, 2015
Fine Tuning of a Type 1 Interferon AntagonistVictoria Urin, Doron Levin, Nanaocha Sharma, et al.
Journal of Cognitive Neuroscience|May 7, 2019
Minimal Recognizable Configurations Elicit Category-selective Responses in Higher Order Visual CortexYael Holzinger, Shimon Ullman, Daniel Harari, et al.
Molecular and Cellular Biology|December 12, 2012
Type I interferons induce apoptosis by balancing cFLIP and caspase-8 independent of death ligandsAmir Apelbaum, Ganit Yarden, Shira Warszawski, et al.
Human Molecular Genetics|February 28, 2015
A robust type I interferon gene signature from blood RNA defines quantitative but not qualitative differences between three major IFNβ drugs in the treatment of multiple sclerosisDaniel Harari, Irit Orr, Ron Rotkopf, et al.
Pageof 3

Showing results (1-10 of 28) with videos related to

Sort By:
Pageof 3
Cognition|November 13, 2018
A model for discovering 'containment' relationsShimon Ullman, Nimrod Dorfman, Daniel Harari
Proceedings of the National Academy of Sciences of the United States of America|September 27, 2012
From simple innate biases to complex visual conceptsShimon Ullman, Daniel Harari, Nimrod Dorfman
Molecular and Cellular Biology|June 22, 2011
Stochastic receptor expression determines cell fate upon interferon treatmentDoron Levin, Daniel Harari, Gideon Schreiber
Proceedings of the National Academy of Sciences of the United States of America|February 18, 2016
Atoms of recognition in human and computer visionShimon Ullman, Liav Assif, Ethan Fetaya, et al.
Molecular and Cellular Biology|July 1, 2009
Receptor density is key to the alpha2/beta interferon differential activitiesIgnacio Moraga, Daniel Harari, Gideon Schreiber, et al.
The British Journal of General Practice : the Journal of the Royal College of General Practitioners|April 5, 2008
Sexual problems in later lifeSteve Iliffe, Kalpa Kharicha, Daniel Harari, et al.
Plos One|July 10, 2015
Fine Tuning of a Type 1 Interferon AntagonistVictoria Urin, Doron Levin, Nanaocha Sharma, et al.
Journal of Cognitive Neuroscience|May 7, 2019
Minimal Recognizable Configurations Elicit Category-selective Responses in Higher Order Visual CortexYael Holzinger, Shimon Ullman, Daniel Harari, et al.
Molecular and Cellular Biology|December 12, 2012
Type I interferons induce apoptosis by balancing cFLIP and caspase-8 independent of death ligandsAmir Apelbaum, Ganit Yarden, Shira Warszawski, et al.
Human Molecular Genetics|February 28, 2015
A robust type I interferon gene signature from blood RNA defines quantitative but not qualitative differences between three major IFNβ drugs in the treatment of multiple sclerosisDaniel Harari, Irit Orr, Ron Rotkopf, et al.
Pageof 3